November 8 (SeeNews) - Luxembourg-based company Aelius has paid to the Serbian government the 16 million euro ($18.5 million) it offered for the purchase of the state-owned 93.7% stake in ailing drug maker Galenika, Belgrade-based media reported on Wednesday.
Aelius is expected to repay by the end of the week Galenika's 25 million euro debt plus a compensation worth 200 euro per every year with the company to the employees who joined is voluntary downsizing plan, news agency Tanjug reported.
You can subscribe to our M&A newsletter here
Serbia's economy ministry said earlier this month it signed a contract for the sale of the Galenika stake to Aelius, a company affiliated to Brazilian pharma group EMS SA.
The Serbian government launched a tender for the sale of its stake in Galenika on September 1. The minimum price was set at 25 million euro, to be used for repayment of Galenika debt, plus 1 euro for the tendering.
($ = 0.8628 euro)